Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Kevin Rue-Albrecht, who has been awarded a Fellowship to improve accessibility and reusability of research software.

The Software Sustainability Institute (SSI) Fellowship Programme offers dedicated support for individuals who champion better research software practices across disciplines. The scheme provides funding, mentorship, and networking opportunities to help Fellows carry out ambitious initiatives that promote sustainable, reproducible, and high-quality software in research.

Dr Kevin Rue-Albrecht, computational biologist and data science trainer in the MRC WIMM Centre for Computational Biology, is one of 25 Fellows selected for SSI’s 2026 Fellowship Programme.

Dr Rue-Albrecht’s work sits at the intersection of collaborative biomedical research, open-source software development, and community training. Kevin is also an active member of the Bioconductor community, a project that develops and maintains thousands of open-source tools used worldwide to analyse modern biological data. 

As research becomes increasingly reliant on interoperable software, communities like Bioconductor each maintain their own systems for labelling and categorising tools. The differences between these systems can make it harder for users to find the right resources and combine them into effective workflows. To address this challenge, a European intergovernmental organisation called ELIXIR created EDAM - a shared vocabulary designed to harmonise how bioinformatics tools and training materials are described across communities.

With the SSI Fellowship, Kevin will work with the Bioconductor and ELIXIR communities to test ways of linking terms between Bioconductor’s vocabulary and the EDAM system. He will collaborate with experts from both groups to produce clear, practical guidance and short tutorials to help developers label their work consistently and make it FAIR (Findable, Accessible, Interoperable, Reusable). He will present this work at workshops across Europe to test and refine the approach with community feedback.

Speaking about the Fellowship, Kevin said:

With tens of millions of downloads each year, Bioconductor tools are used by researchers around the world, yet many remain difficult to locate in major online catalogues. Through this Fellowship, I aim to change that by improving how Bioconductor’s software and training materials appear in the places that scientists search. This will make it easier for users to discover the right tools, build reliable workflows, and share their results.

Learn more about the 2026 Fellows on SSI’s website: Introducing the 2026 Fellowship Cohort: Insights and Celebrations

Similar stories

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.

First real-world trial shows AI could reduce need for contrast injections in heart MRI scans

The technology could make advanced heart MRI faster, cheaper and more accessible.

Beyond cancer dependency maps: the PRECISE vision

Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.

Similar stories

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.

First real-world trial shows AI could reduce need for contrast injections in heart MRI scans

The technology could make advanced heart MRI faster, cheaper and more accessible.

Beyond cancer dependency maps: the PRECISE vision

Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.